Skip to main content
. 2004 Sep;72(9):4956–4965. doi: 10.1128/IAI.72.9.4956-4965.2004

TABLE 1.

Peripheral blood counts in control IgG-treated and RB6-treated micea

Mouse strain Treatment Day % of total counts
Neutrophils Lymphocytes Monocytes Eosinophils
C3H IgG 0 32.2 25.7 41.9 0.7
RB6 0 1.0 42.5 56.0 0.5
DBA IgG 0 23.1 23.9 53.0 0.0
RB6 0 0.0 30.7 68.9 0.4
C3H IgG 7 24.1 ± 7.6 46.7 ± 6.0 27.8 ± 1.9 1.3 ± 0.7
RB6 7 4.6 ± 3.6 44.3 ± 9.9 51.2 ± 6.7 0.0 ± 0.0
DBA IgG 7 25.0 ± 9.4 57.1 ± 5.2 17.2 ± 5.2 0.4 ± 0.6
RB6 7 0.9 ± 1.3 49.2 ± 2.4 46.1 ± 1.9 0.0 ± 0.0
C3H IgG 14 36.0 30.7 32.9 0.4
RB6 14 0.0 44.4 55.3 0.3
DBA IgG 14 27.8 38.7 33.2 0.3
RB6 14 0.4 37.5 61.7 0.4
C3H IgG 21 50.9 ± 0.1 22.8 ± 7.0 25.4 ± 7.4 1.0 ± 0.2
RB6 21 5.8 ± 0.6 48.6 ± 4.0 44.9 ± 4.9 0.8 ± 0.9
DBA IgG 21 33.7 ± 6.0 36.6 ± 2.1 31.3 ± 8.0 0.3 ± 0.2
RB6 21 6.6 ± 3.9 61.4 ± 4.0 30.0 ± 1.6 2.1 ± 0.5
a

Mice were given daily intraperitoneal injections of 200 μg of control IgG or RB6 beginning on day −1. Mice were infected with 2.5 × 105 B. burgdorferi cells on day 0 and blood was collected from the retroorbital plexus weekly. Blood smears were stained with Diff-Quick, and at least 200 cells per slide were counted. On days 0 and 14 one mouse per treatment per mouse strain was randomly chosen for bleeding. On days 7 and 21 groups of three mice were bled, and the data are averages ± standard deviations. The data are representative of at least four separate experiments.